Back to search

Article

TNFAIP8 is a novel phosphoinositide-binding inhibitory regulator of Rho GTPases that promotes cancer cell migration

2021-03-26

Abstract excerpt

<h4>SUMMARY</h4> More than half of human tumors exhibit aberrantly dysregulated phosphoinositide signaling, yet how this is controlled remains not fully understood. While somatic mutations of PI3K, PTEN and Ras account for many cases of the hyperactivated lipid signals, other mechanisms for these dysfunctions in cancer are also being discovered. We report here that TNFAIP8 interacts with PtdIns(4,5) P 2 and PtdI...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work
6726764d-dacc-5f7f-8a54-f53431148742
DOI
10.1101/2021.03.26.437243
Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest
Interactive article relationship graphSelect a related publication card to move it into the centre and load its closest explainable connections. Solid lines are source-backed structured connections. Dashed lines are semantic discovery signals and are not scientific evidence.
TNFAIP8 is a novel phosphoinositide-binding inhibitory regulator of Rho GTPases that promotes cancer cell migrationDOI 10.1101/2021.03.26.437243
Select a neighboring publication to make it the new centre.